SCOPUS 정보 검색 플랫폼

Lung Cancer

Volumn 45, Issue SUPPL., 2004, Pages

Pathology of malignant mesothelioma

(1) Van Marck, Eric a

a ANTWERP UNIVERSITY HOSPITAL (Belgium)

Author keywords

Calretinin; Malignant mesothelioma; Neoplastic mesothelium; Telomerase activity

Indexed keywords

TELOMERASE;

CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; CYTOLOGY; EVIDENCE BASED MEDICINE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; TUMOR CELL;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; PLEURAL DISEASES; PLEURAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 3142677840 PISSN: 01695002 EISSN: None Source Type: Journal
DOI: 10.1016/j.lungcan.2004.04.006 Document Type: Conference Paper

Times cited : (12)

References (7)

1
- 0031758655
- Telomerase activity in human pleural mesothelioma
- Dhaene K., Hubner R., Kumar-Singh S., Weyn B., Van Marck E. Telomerase activity in human pleural mesothelioma. Thorax. 53:1998;915-918
- (1998) Thorax , vol.53 , pp. 915-918
- Dhaene, K.¹ Hubner, R.² Kumar-Singh, S.³ Weyn, B.⁴ Van Marck, E.⁵

2
- 0033972309
- Expression profile of telomerase subunits in human pleural mesothelioma
- Dhaene K., Wauters J., Weyn B., Timmermans J.P., Van Marck E. Expression profile of telomerase subunits in human pleural mesothelioma. J. Pathol. 190:2000;80-85
- (2000) J. Pathol. , vol.190 , pp. 80-85
- Dhaene, K.¹ Wauters, J.² Weyn, B.³ Timmermans, J.P.⁴ Van Marck, E.⁵

3
- 0034833122
- Commentary. Immunohistochemistry and the diagnosis of malignant mesothelioma
- King J.E., Hasleton P.S. Commentary. Immunohistochemistry and the diagnosis of malignant mesothelioma. Histopathology. 38:2001;471-476
- (2001) Histopathology , vol.38 , pp. 471-476
- King, J.E.¹ Hasleton, P.S.²

4
- 0036187373
- Expression of telomerase reverse transcriptase (TERT) in malignant mesothelioma
- Kumaki F., Kawai T., Churg A., Galateau-Salle F.B., Hasleton P., Henderson D., et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesothelioma. Am. J. Surg. Pathol. 26:2002;365-370
- (2002) Am. J. Surg. Pathol. , vol.26 , pp. 365-370
- Kumaki, F.¹ Kawai, T.² Churg, A.³ Galateau-Salle, F.B.⁴ Hasleton, P.⁵ Henderson, D.⁶

5
- 0031056053
- WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis
- Kumar-Singh S., Segers K., Rodeck U., Backhovens H., Bogers J., Weyler J., et al. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J. Pathol. 181:1997;67-74
- (1997) J. Pathol. , vol.181 , pp. 67-74
- Kumar-Singh, S.¹ Segers, K.² Rodeck, U.³ Backhovens, H.⁴ Bogers, J.⁵ Weyler, J.⁶

6
- 0026598365
- Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium
- Ramael M., Buysse C., van den Bossche J., Segers K., Van Marck E. Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium. J. Pathol. 167:1992;1-4
- (1992) J. Pathol. , vol.167 , pp. 1-4
- Ramael, M.¹ Buysse, C.² Van Den Bossche, J.³ Segers, K.⁴ Van Marck, E.⁵

7
- 0026545380
- Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1
- Ramael M., van den Bossche J., Buysse C., van Meerbeeck J., Segers K., Vermeire P., et al. Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1. J. Pathol. 167:1992;5-8
- (1992) J. Pathol. , vol.167 , pp. 5-8
- Ramael, M.¹ Van Den Bossche, J.² Buysse, C.³ Van Meerbeeck, J.⁴ Segers, K.⁵ Vermeire, P.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.